000 01270 a2200325 4500
005 20250517140605.0
264 0 _c20171218
008 201712s 0 0 eng d
022 _a1535-4970
024 7 _a10.1164/rccm.201607-1401LE
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrotberg, James B
245 0 0 _aDid Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome?
_h[electronic resource]
260 _bAmerican journal of respiratory and critical care medicine
_cFeb 2017
300 _a538-540 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAdult
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aPulmonary Surfactants
_xtherapeutic use
650 0 4 _aRespiratory Distress Syndrome
_xdrug therapy
650 0 4 _aRespiratory Distress Syndrome, Newborn
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aFiloche, Marcel
700 1 _aWillson, Douglas F
700 1 _aRaghavendran, Krishnan
700 1 _aNotter, Robert H
773 0 _tAmerican journal of respiratory and critical care medicine
_gvol. 195
_gno. 4
_gp. 538-540
856 4 0 _uhttps://doi.org/10.1164/rccm.201607-1401LE
_zAvailable from publisher's website
999 _c26881919
_d26881919